vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and FONAR CORP (FONR). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $25.5M, roughly 1.2× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs -438.1%, a 446.2% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 2.4%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
DOMH vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $25.5M |
| Net Profit | $-131.8M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | -8.9% | 13.5% |
| Net Margin | -438.1% | 8.0% |
| Revenue YoY | 220.4% | 2.4% |
| Net Profit YoY | -12426.2% | 4.7% |
| EPS (diluted) | $-6.94 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $25.5M | ||
| Q3 25 | $50.8M | $26.0M | ||
| Q2 25 | $34.1M | $27.3M | ||
| Q1 25 | $8.1M | $27.2M | ||
| Q4 24 | $9.4M | $24.9M | ||
| Q3 24 | $4.0M | $25.0M | ||
| Q2 24 | $6.2M | $25.9M | ||
| Q1 24 | $1.4M | $25.7M |
| Q4 25 | $-131.8M | $2.1M | ||
| Q3 25 | $125.2M | $2.3M | ||
| Q2 25 | $16.6M | $729.3K | ||
| Q1 25 | $-32.5M | $2.5M | ||
| Q4 24 | $1.1M | $2.0M | ||
| Q3 24 | $-4.2M | $3.1M | ||
| Q2 24 | $-6.1M | $830.4K | ||
| Q1 24 | $-5.4M | $1.9M |
| Q4 25 | -8.9% | 13.5% | ||
| Q3 25 | -3.1% | 14.1% | ||
| Q2 25 | -57.0% | 5.3% | ||
| Q1 25 | -394.6% | 15.2% | ||
| Q4 24 | 0.4% | 11.9% | ||
| Q3 24 | -79.1% | 21.0% | ||
| Q2 24 | -44.3% | 7.4% | ||
| Q1 24 | -205.2% | 16.8% |
| Q4 25 | -438.1% | 8.0% | ||
| Q3 25 | 246.4% | 8.7% | ||
| Q2 25 | 48.7% | 2.7% | ||
| Q1 25 | -400.5% | 9.2% | ||
| Q4 24 | 11.4% | 7.9% | ||
| Q3 24 | -104.2% | 12.6% | ||
| Q2 24 | -99.1% | 3.2% | ||
| Q1 24 | -398.0% | 7.3% |
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | — | ||
| Q2 25 | $1.12 | — | ||
| Q1 25 | $-3.02 | — | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | — | ||
| Q2 24 | $-1.01 | — | ||
| Q1 24 | $-0.91 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $176.9M |
| Total Assets | $112.9M | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $121.0K | ||
| Q3 25 | $176.2M | $122.0K | ||
| Q2 25 | $28.2M | $56.5M | ||
| Q1 25 | $18.9M | $123.0K | ||
| Q4 24 | $8.2M | $121.0K | ||
| Q3 24 | $7.2M | $136.0K | ||
| Q2 24 | $12.1M | $56.5M | ||
| Q1 24 | $7.1M | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $69.4M | $176.9M | ||
| Q3 25 | $210.2M | $174.9M | ||
| Q2 25 | $88.6M | $172.6M | ||
| Q1 25 | $42.4M | $171.9M | ||
| Q4 24 | $39.9M | $169.8M | ||
| Q3 24 | $38.3M | $168.7M | ||
| Q2 24 | $42.4M | $166.0M | ||
| Q1 24 | $47.7M | $165.8M |
| Q4 25 | $112.9M | $217.2M | ||
| Q3 25 | $223.4M | $218.4M | ||
| Q2 25 | $109.3M | $216.9M | ||
| Q1 25 | $52.3M | $214.9M | ||
| Q4 24 | $47.1M | $208.0M | ||
| Q3 24 | $43.4M | $212.3M | ||
| Q2 24 | $49.1M | $214.2M | ||
| Q1 24 | $52.2M | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $171.0K |
| Free Cash FlowOCF − Capex | — | $-227.0K |
| FCF MarginFCF / Revenue | — | -0.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $171.0K | ||
| Q3 25 | $-4.9M | $1.7M | ||
| Q2 25 | $-353.0K | $4.2M | ||
| Q1 25 | $1.2M | $3.1M | ||
| Q4 24 | $-16.7M | $2.2M | ||
| Q3 24 | $-4.7M | $1.7M | ||
| Q2 24 | $1.4M | $4.6M | ||
| Q1 24 | $-8.6M | $2.8M |
| Q4 25 | — | $-227.0K | ||
| Q3 25 | — | $-177.0K | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | -0.9% | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.04× | 0.75× | ||
| Q2 25 | -0.02× | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | -15.65× | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× | ||
| Q1 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
